A PBPK modeling approach for personalized dose optimization of nicardipine in renal and hepatic dysfunction
Abstract Nicardipine is a calcium channel blocker employed to manage hypertension and angina. It is primarily metabolized in the liver; therefore, hepatic impairment patients may experience drug accumulation, potentially resulting in adverse events. This research aims to design physiologically based...
Saved in:
| Main Authors: | Ammara Ayub, Ammara Zamir, Muhammad Fawad Rasool, Usman Arshad, Faleh Alqahtani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-03829-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Esmolol and Nicardipine treatment in hypertensive acute ıschemic stroke patients
by: Adem Melekoğlu, et al.
Published: (2025-04-01) -
Comparison of the effects of nicardipine and remifentanil on surgical visual field and hemodynamic parameters in tympanomastoidectomy cases
by: Celal Saritoy, et al.
Published: (2024-04-01) -
Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic Impairment
by: Mohammed S. Alasmari, et al.
Published: (2024-12-01) -
Comparison of nicardipine versus labetalol for time to alteplase administration in acute ischemic stroke
by: Alex Huang, et al.
Published: (2025-07-01) -
Repurposing nicardipine leads to improved development in a young patient with Pitt–Hopkins syndrome
by: Marta Agnes Somorai, et al.
Published: (2025-07-01)